NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

INGN

Inogen Inc

Jul 03 • 03:46PM ET

7.49

Dollar change +0.07
Percentage change 0.94	%

Healthcare • Medical Devices • USA • NASD

Peers: RMD ABT ISRG BSX PHG BDX GEHC MDT ZBH AAPL

| Held by: VTI IWM VXF IWN DFAT VTWO DFAS IWC VFMO PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.14	Insider Own	13.77%	Shs Outstand	26.89M	Perf Week	4.10%
Market Cap	201.39M	Forward P/E	-	EPS next Y	-0.84	Insider Trans	0.40%	Shs Float	23.19M	Perf Month	17.21%
Enterprise Value	98.06M	PEG	-	EPS next Q	-0.27	Inst Own	70.44%	Short Float	4.67%	Perf Quarter	4.03%
Income	-27.48M	P/S	0.59	EPS this Y	31.80%	Inst Trans	-2.95%	Short Ratio	3.99	Perf Half Y	-17.78%
Sales	339.96M	P/B	1.02	EPS next Y	19.29%	ROA	-8.81%	Short Interest	1.08M	Perf YTD	-18.32%
Book/sh	7.36	P/C	1.64	EPS next 5Y	24.85%	ROE	-14.10%	52W High	13.33 -43.81%	Perf Year	-4.34%
Cash/sh	4.56	P/FCF	-	EPS past 3/5Y	-75.31% -	ROIC	-12.83%	52W Low	5.70 31.40%	Perf 3Y	-69.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.12% -1.49%	Gross Margin	50.53%	Volatility	4.24% 4.28%	Perf 5Y	-78.44%
Dividend TTM	-	EV/Sales	0.29	EPS Y/Y TTM	72.50%	Oper. Margin	-9.10%	ATR (14)	0.32	Perf 10Y	-83.34%
Dividend Ex-Date	-	Quick Ratio	2.67	Sales Y/Y TTM	5.73%	Profit Margin	-8.08%	RSI (14)	68.13	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	3.07	EPS Q/Q	60.61%	SMA20	10.34%	Beta	1.73	Target Price	11.67
Payout	-	Debt/Eq	0.10	Sales Q/Q	5.45%	SMA50	12.16%	Rel Volume	0.33	Prev Close	7.42
Employees	766	LT Debt/Eq	0.08	Earnings	May 07 AMC	SMA200	-12.75%	Avg Volume	271.36K	Price	7.49
IPO	Feb 14, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.52% 3.41%	Trades		Volume	89,356	Change	0.94%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	B. Riley Securities	Buy	$14
May-22-25	Upgrade	Needham	Hold → Buy	$12
Feb-15-24	Upgrade	William Blair	Mkt Perform → Outperform
Aug-08-23	Downgrade	JP Morgan	Overweight → Neutral	$15 → $8
Jul-14-23	Downgrade	Needham	Buy → Hold
Jan-17-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-09-21	Upgrade	Needham	Hold → Buy	$47
Nov-02-21	Upgrade	JP Morgan	Underweight → Neutral	$45
Aug-05-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-04-21	Upgrade	William Blair	Mkt Perform → Outperform
Dec-14-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$60
Jul-23-20	Downgrade	Needham	Buy → Hold
May-06-20	Reiterated	Needham	Buy	$80 → $75
Nov-06-19	Upgrade	Needham	Hold → Buy	$90
Sep-13-19	Reiterated	Piper Jaffray	Overweight	$80 → $80
Aug-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$78 → $47
Aug-08-19	Downgrade	Stifel	Buy → Hold
Aug-07-19	Downgrade	Needham	Buy → Hold
Jun-28-19	Downgrade	Needham	Strong Buy → Buy	$111 → $91
May-08-19	Reiterated	Needham	Strong Buy	$191 → $111

Show Previous Ratings

Jun-23-25 08:30AM	Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy (Business Wire)
Jun-06-25 11:31AM	Inogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound? (Zacks)
May-28-25 09:14AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
04:41AM	Zacks.com featured highlights Urban Outfitters, Inogen and Southwest Gas (Zacks)
May-27-25 09:10AM	3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties (Zacks)
04:34PM	Loading…
May-22-25 04:34PM	Needham Upgrades Inogen (INGN) to Buy (Insider Monkey) +13.26%
May-16-25 12:00PM	What Makes Inogen (INGN) a New Buy Stock (Zacks) +5.91%
09:35AM	After Plunging -15.69% in 4 Weeks, Here's Why the Trend Might Reverse for Inogen (INGN) (Zacks)
May-08-25 12:06PM	INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y (Zacks) -11.44%
03:36AM	Inogen Inc (INGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... (GuruFocus.com)
May-07-25 08:18PM	Inogen targets $352M-$355M in 2025 revenue with focus on B2B growth and strategic innovations (Seeking Alpha)
08:16PM	Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
05:55PM	Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:53PM	Inogen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Inogen Announces First Quarter 2025 Financial Results (Business Wire)
10:00AM	Here are the major earnings after the close today (Seeking Alpha)
May-06-25 10:13AM	MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN (Zacks)
May-01-25 05:45PM	Mettler-Toledo (MTD) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-16-25 08:30AM	Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
Mar-27-25 11:30AM	Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-20-25 08:30AM	Inogen To Present at 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-13-25 09:30AM	Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -5.46%
Feb-26-25 07:41AM	Q4 2024 Inogen Inc Earnings Call (Thomson Reuters StreetEvents) -14.81%
02:17AM	Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... (GuruFocus.com)
Feb-25-25 05:55PM	Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Inogen: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
01:51AM	Inogen Inc (INGN) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
04:00PM	Loading…
Feb-03-25 04:00PM	Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West (Business Wire)
Jan-26-25 12:00PM	Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell (Business Wire)
Jan-24-25 12:00PM	Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Jan-13-25 04:00PM	Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue (Business Wire) +8.17%
Dec-31-24 08:58AM	Inogen Expands U.S. Market with FDA Clearance (TipRanks)
05:20AM	FDA grants clearance for Inogens SIMEOX 200 airway clearance device (Medical Device Network)
Dec-30-24 08:30AM	Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device (Business Wire) +6.18%
Nov-25-24 09:55AM	Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Nov-08-24 08:00PM	Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +17.23%
04:02AM	Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges (GuruFocus.com)
Nov-07-24 06:10PM	Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:05PM	Inogen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Third Quarter 2024 Financial Results (Business Wire)
04:04PM	Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations (GlobeNewswire)
09:16AM	Inogen, Inc. (INGN): A Bear Case Theory (Insider Monkey)
Nov-06-24 07:43AM	Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 08:30AM	Inogen to Present at Upcoming Investor Conferences (Business Wire)
Oct-17-24 08:30AM	Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 (Business Wire)
Oct-09-24 05:09PM	Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges (GuruFocus.com)
Oct-08-24 08:30AM	Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC (Business Wire)
Sep-05-24 08:30AM	Inogen Appoints Eric Pauls as Vice President of Sales, North America (Business Wire)
Aug-22-24 01:16PM	Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock? (Zacks)
Aug-08-24 12:00PM	Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +5.32%
Aug-07-24 11:34AM	Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks) +35.95%
Aug-06-24 06:05PM	Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:06PM	Inogen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Second Quarter 2024 Financial Results (Business Wire)
Jul-22-24 06:24AM	3 Stocks Under $10 With the Potential for Massive Gains (InvestorPlace)
Jul-16-24 08:30AM	Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire) +6.09%
Jul-15-24 09:00AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now (Zacks)
Jul-03-24 04:10PM	Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development (Business Wire) +5.35%
Jun-06-24 11:31AM	Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-03-24 04:05PM	Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio (Business Wire) -5.28%
May-09-24 01:29PM	Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y (Zacks) +5.46%
May-08-24 01:27PM	Inogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call Transcript (Insider Monkey) +12.88%
07:14AM	Q1 2024 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Inogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ... (GuruFocus.com)
May-07-24 09:55PM	INGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
06:33PM	Inogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on Growth (GuruFocus.com)
05:32PM	Inogen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces First Quarter 2024 Financial Results (Business Wire)
Apr-10-24 08:30AM	Inogen to Report First Quarter 2024 Financial Results on May 7, 2024 (Business Wire)
Mar-28-24 11:30AM	Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue? (Zacks)
11:26AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Mar-25-24 08:30AM	Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference (Business Wire) +6.36%
Mar-07-24 04:00PM	Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire) +7.25%
Feb-29-24 08:28AM	Inogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.72%
Feb-28-24 09:22AM	Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves (Zacks) -32.66%
06:47AM	Q4 2023 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 07:30PM	Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:25PM	Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
05:30PM	Inogen: Q4 Earnings Snapshot (Associated Press Finance)
04:48PM	Inogen Inc (INGN) Reports Decline in 2023 Revenue and Widening Net Loss (GuruFocus.com)
04:05PM	Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-26-24 09:15AM	Gear Up for Inogen (INGN) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Feb-23-24 09:00AM	3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio for Now (Zacks)
Feb-01-24 07:03AM	Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains? (Zacks)
Jan-30-24 04:00PM	Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 (Business Wire) +5.58% +12.31%
Jan-24-24 04:00PM	Inogen Names Michael Bourque as New Chief Financial Officer (Business Wire) +5.82%
Jan-08-24 07:10AM	Inogen (INGN) Soars 15.4%: Is Further Upside Left in the Stock? (Zacks) +7.66%
Jan-02-24 09:29AM	3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio (Zacks)
Dec-07-23 11:31AM	Inogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound? (Zacks) +16.43%
Nov-13-23 08:30AM	Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO (Business Wire)
Nov-10-23 09:30AM	Inogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Nov-09-23 02:30PM	Inogen to Present at Upcoming Investor Conferences in November 2023 (Business Wire) -7.68%
Nov-08-23 11:09AM	Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
09:57AM	Inogen, Inc. (NASDAQ:INGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 04:36PM	Inogen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Third Quarter 2023 Financial Results (Business Wire)

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bourque Michael J.	EVP, CFO & Treasurer	Mar 01 '25	Option Exercise	0.00	25,000	0	25,600	Mar 04 06:42 PM
Bourque Michael J.	EVP, CFO & Treasurer	Mar 03 '25	Buy	8.32	3,000	24,960	47,646	Mar 04 06:42 PM
Smith Kevin Raymond Merrill	CEO and President	Mar 01 '25	Option Exercise	0.00	28,333	0	44,387	Mar 04 06:41 PM
Smith Kevin Raymond Merrill	CEO and President	Mar 03 '25	Buy	8.56	11,709	100,245	70,274	Mar 04 06:41 PM
Smith Kevin Raymond Merrill	CEO and President	Dec 01 '24	Option Exercise	0.00	28,333	0	28,333	Dec 03 05:08 PM
Ramade Gregoire	Chief Commercial Officer	Dec 01 '24	Option Exercise	0.00	31,565	0	31,565	Dec 03 05:05 PM
JASON SOMER	Officer	Aug 09 '24	Proposed Sale	12.03	4,690	56,423		Aug 09 04:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INGN

Inogen Inc

Upgrade your FINVIZ experience